Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 405 | 1,198 | 3,196 | 10,460 | 14,548 |
| Marketable Securities | N/A | N/A | 154 | 0 | 80 |
| Receivables | 34 | 39 | 107 | 125 | 175 |
| Inventories | 1,360 | 1,540 | 2,651 | 3,548 | 5,478 |
| Other current assets | 1,097 | 928 | 358 | 978 | 3,236 |
| TOTAL | $2,896 | $3,705 | $6,466 | $15,111 | $23,517 |
| Non-Current Assets | |||||
| PPE Net | 3,220 | 3,695 | 8,213 | 9,419 | 10,840 |
| Investments And Advances | 0 | 0 | 0 | 0 | 12 |
| Intangibles | 1,852 | 1,616 | 1,170 | 917 | 407 |
| Other Non-Current Assets | 779 | 886 | 1,329 | 1,387 | 1,091 |
| TOTAL | $5,851 | $6,197 | $10,712 | $11,723 | $12,350 |
| Total Assets | $8,747 | $9,902 | $17,178 | $26,834 | $35,867 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 304 |
| Accounts payable and accrued liabilities | 883 | 773 | 530 | 981 | 476 |
| Accrued Expenses | 1,374 | 1,567 | 1,368 | 1,460 | 1,588 |
| TOTAL | $2,257 | $2,340 | $1,898 | $2,441 | $2,368 |
| Non-Current Liabilities | |||||
| Long Term Debt | 134 | 137 | 141 | 144 | 276 |
| Other Non-Current Liabilities | 26 | 104 | 228 | 357 | 420 |
| TOTAL | $160 | $241 | $369 | $501 | $696 |
| Total Liabilities | $2,417 | $2,581 | $2,267 | $2,942 | $3,064 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,892 | 75,636 | 53,077 | 51,744 | 48,327 |
| Common Shares | 130,570 | 124,409 | 118,965 | 116,019 | 109,720 |
| Retained earnings | -120,744 | -113,665 | -100,665 | -89,159 | -74,143 |
| Other shareholders' equity | -3,496 | -3,423 | -3,389 | -2,968 | -2,774 |
| TOTAL | $6,330 | $7,321 | $14,911 | $23,892 | $32,803 |
| Total Liabilities And Equity | $8,747 | $9,902 | $17,178 | $26,834 | $35,867 |